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Arrangements for hospital infection control in the UK have
been in place for a number of years.They have been described
in the two reports of the Hospital InfectionWorking Group
which were published in 1988 [1] and in 1995 [2]. Essentially,
these reports described the good practice that already existed
inmany hospitals.
Put very brie£y, the ¢rst report [1] recommended: the
establishment of an infection control committee to formulate
policies and programmes; the appointment of an Infection
Control Team (ICT) comprising an Infection Control Doctor
and an Infection Control Nurse, to carry out the day-to-day
work; and, in the event of an outbreak, the formation of an
Action Group.
It also stressed the importance of infection control in long-
stay units and the need to use the nationally available expert
advice from universities and the Public Health Laboratory
Service.
The arrangements recognized a number of signi¢cant
aspects of infection control in the UK. These included the
important role of the clinical microbiologist and the micro-
biology laboratory as well as the increasing importance of the
Infection Control Nurse.
The pragmatic day-to-day direct intervention approach
current in this country was appreciated.
The second report [2] included a new chapter on the sur-
veillance of hospital infection and recognized the role of the
Consultant in Communicable Disease Control, a new post
established since the ¢rst report. Changes in medical practice
and the increasing importance of the private sector were also
recognized.
While there have been some problems with these arrange-
ments, they have generally worked well and been widely
accepted. One of the main di¤culties has been that of imple-
mentation with appropriate sta¤ng levels, and a concern has
been the level of priority awarded to infection control when
competing for scarce resources.
There have been a number of recent changes which may
impact on this situation.
There has been interest for some time in the costs of hospital
infection, and the recent study on the socio-economic burden
of hospital-acquired infection examined these in greater detail
than has been done previously [3].
The development of the Nosocomial Infection National
Surveillance Scheme [4] (NINSS) is likely to focus attention
on variations in infection rates between hospitals and provide
a tool to address these di¡erences.
The changes in theUK are, however, only part of far-reach-
ing changes which are a¡ectingmany European countries.
We are all aware of the many e¡ects that an aging popula-
tion is having on our society, and the increasing signi¢cance of
infections in the elderly is one example of this.
Public expectations of healthcare are rising, and infection
is no longer so readily accepted as an unpleasant but unavoid-
able aspect of some medical and surgical procedures and this is
havingmedico-legal consequences in manycountries.
The introduction of a variety of new technologies into
healthcare has increased the risks of infection and to an extent
altered their nature.
International concern about antibiotic resistance was
re£ected at an EUconference in 1998 [5], and the role of infec-
tion control in preventing the spread of resistant organisms is
well recognized. In this country, this was exempli¢ed by the
Health Service Circular `Resistance to Antibiotics and other
Antimicrobial Agents' [6], which placed considerable empha-
sis on infection control.
In some parts of Europe, service recon¢guration with an
increasing role for primary care is taking place.
The importance of cost containment when considered
alongside our knowledge of the costs of hospital-acquired
infection must have an e¡ect, as will increased emphasis on
measurement of quality and performance in healthcare provi-
sion. Indeed, hospital infection rates are often considered to be
amarker for a number of aspects of quality of care.
In the UK, these internationally occurring changes have
resulted in the development of Primary CareTrusts and in the
creation of the National Institute for Clinical Excellence
(NICE), and the Commission for Health Improvement (CHI)
and in Clinical Governance [7]. Some of these changes will
certainly a¡ect the way in which hospital infection control is
practised in this country.
Of course, it is di¤cult to foresee what the changes will
be, but the following seem to be some of the possibilities.
There may be greater formality concerning the structures
for hospital infection control and for hospital infection con-
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trol policies and protocols. This will result from the role of
the HSE, the involvement of the NAO and greater manage-
ment involvement which is likely to occur as part of Clinical
Governance.
Because of clinical governance and also because of CHI,
clinical teams may become more concerned about their infec-
tion rates and more involved. Surveillance is likely to become
of greater importance and may well be performed by clinical
teams themselves, and infection rateswill become increasingly
recognized as indicators of quality care.
If these changes work well, they should result in greater
integration of hospital infection control into the day-to-day
activities of the hospital, with the Infection ControlTeam act-
ing very much as part of a multidisciplinary team concerned
with all aspects of hospital infection control. The role of the
Infection Control Team as a source of advice and expertise
would then become increasingly important, and the training
of InfectionControlTeamswill therefore be evenmore signif-
icant than it is now.
This type of approach to hospital infection control appears
in many ways to be an attractive one and could provide a
sound basis from which future infection control problems
could bemet.
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